World's Best Scientists 2026 revealed!
Journal of Ocular Pharmacology and Therapeutics
H-index 15

Journal of Ocular Pharmacology and Therapeutics

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2126 22 24 12

Additional Metrics

Number of Best Scientists*: 58
Documents by Best Scientists*: 54
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 76
SCIMAGO SJR: 0.597
Impact Factor: 2.1

Overview

Top Research Topics at Journal of Ocular Pharmacology and Therapeutics?

The journal focuses on Ophthalmology, Surgery, Intraocular pressure, Anesthesia and Pharmacology. Journal of Ocular Pharmacology and Therapeutics focused on Ophthalmology research but expanded to cover Bevacizumab. The journal concentrates on Surgery topics that focus on Retrospective cohort study and Prospective cohort study.

Topics in Intraocular pressure were tackled in line with various other fields like Internal medicine and Glaucoma. Specifically, studies on Open angle glaucoma are prevalent in the Glaucoma works discussed. Most of the works presented in the journal deals with Anesthesia but it intersects with the subject of Timolol.

The Pharmacology study tackled is a key component of adjacent topics in the area of In vivo. Macular edema is a focus of the Visual acuity works in Journal of Ocular Pharmacology and Therapeutics. The work on Cornea addressed in the journal expands to the thematically related Lagomorpha.

  • Ophthalmology (29.19%)
  • Surgery (19.73%)
  • Intraocular pressure (19.61%)

What are the most cited papers published in the journal?

  • Topical Ocular Drug Delivery: Recent Developments and Future Challenges (429 citations)
  • Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. (403 citations)
  • Glutathione: a vital lens antioxidant. (303 citations)

Research areas of the most cited articles at Journal of Ocular Pharmacology and Therapeutics:

The most cited articles focus largely on the fields of Ophthalmology, Surgery, Intraocular pressure, Anesthesia and Pharmacology. The journal articles with studies in Ophthalmology featured incorporate elements of Corticosteroid and Prospective cohort study. The works on Intraocular pressure tackled in the most cited publications bring together disciplines like Internal medicine, Endocrinology and Glaucoma.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Pharmacology

The previous edition focused in particular on these issues:

The journal is mainly concerned with subjects like Pharmacology, Ophthalmology, Retinal, In patient and Glaucoma. Journal of Ocular Pharmacology and Therapeutics explores topics in Pharmacology which can be helpful for research in disciplines like Emulsion, Apoptosis, Neovascularization and In vivo. The majority of Ophthalmology studies presented zero in on Vitrectomy.

In addition to Retinal research, Journal of Ocular Pharmacology and Therapeutics aims to explore topics under Inflammation, Retina and Cell biology. The In patient study tackled in it also covered diverse fields such as Anesthesia and Internal medicine. The studies in Glaucoma featured incorporate elements of Intraocular pressure and Benzalkonium chloride.

The most cited articles from the last journal are:

  • Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients. (4 citations)
  • Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema. (2 citations)
  • Effects of Glycyrrhizin Treatment on Diabetic Cornea. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Ocular Pharmacology and Therapeutics (based on the number of publications) are:

  • George C.Y. Chiou (74 papers) absent at the last edition,
  • Ashim K. Mitra (25 papers) absent at the last edition,
  • William C. Stewart (23 papers) absent at the last edition,
  • David A. Lee (20 papers) absent at the last edition,
  • Hitoshi Shichi (19 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Ocular Pharmacology and Therapeutics (based on the number of publications) are:

  • Texas A&M University (59 papers) absent at the last edition,
  • National Taiwan University (31 papers) published 1 paper at the last edition the same number as at the previous edition,
  • SANTEN PHARMACEUTICAL CO., LTD. (30 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • National Institutes of Health (30 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Allergan (28 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.59% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.64% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.06% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.15% of all publications and 65.15% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Understanding the Submission Process

The submission process for the Journal of Ocular Pharmacology and Therapeutics is straightforward for authors seeking to publish their research work. First and foremost, research papers should meet all the applicable ethical standards for scientific study. Secondly, authors should ensure their papers align with the themes of the journal.

Prospective authors should adequately format their manuscripts according to the guidelines provided by the journal. It's also critical that the manuscripts are coherent, concise, and clearly written, contributing to the body of knowledge in the field. Adequate referencing and citation are also essential to give credit to other researchers and prevent plagiarism.

Once the manuscript is ready for submission, authors can submit it through the journal's online submission platform. It's here that they'll need to provide all relevant author information – including affiliations, acknowledgements, and sources of funding. After submission, the manuscript will undergo a peer review process for assessment. Post-review, authors might need to make revisions before final acceptance and publication in the journal.

If you're considering pursuing a career in a field related to ocular pharmacology and need a solid foundation in healthcare, you might want to look into the {anchor}best nursing schools in Iowa{/anchor}. With a focus on both theoretical knowledge and practical skills, these programs can prepare you for a successful career in healthcare and give you a strong background for advanced study in fields like ocular pharmacology.

Top Publications

  • Matrix Metalloproteinases and Glaucoma Treatment.

    Robert N. Weinreb;Michael R. Robinson;Mohammed Dibas;W. Daniel Stamer

    (2020)
    84 Citations
  • Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.

    (2023)
    41 Citations
  • Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial

    Doreen Schmidl;Ahmed M. Bata;Stephan Szegedi;Valentin Aranha Dos Santos

    (2020)
    35 Citations
  • Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease

    Philippe Daull;Mourad Amrane;Dahlia Ismail;Georgi Georgiev

    (2020)
    29 Citations
  • Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

    (2022)
    21 Citations
  • Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review.

    (2023)
    20 Citations
  • Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients.

    Yuko Maruyama;Yoko Ikeda;Kazuhiko Mori;Kengo Yoshii

    (2020)
    17 Citations
  • Calcineurin Inhibitor Voclosporin Preserves Corneal Barrier and Conjunctival Goblet Cells in Experimental Dry Eye.

    Jehan Alam;Rodrigo G de Souza;Zhiyuan Yu;Michael E Stern

    (2020)
    16 Citations
  • Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye

    Xiaolan Chen;Sujin Lee;Tianyi Zhang;Tianying Duan

    (2020)
    14 Citations
  • Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.

    Charles B. Wright;Steven M. Becker;Lucie A. Low;Danilo A. Tagle

    (2020)
    13 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine in the USA, exploring related fields can offer valuable alternatives and complementary career options. One popular area is exercise science, where an exercise science degree online accredited programs provide education focused on physical health, fitness, and rehabilitation. These programs prepare graduates for roles in sports medicine, physical therapy, and wellness coaching.

Similarly, an online kinesiology bachelor's degree offers deep insights into human movement and biomechanics. This degree often serves as a foundation for careers in physical therapy, occupational therapy, or fitness training, and can be a stepping stone for further medical education.

For healthcare professionals seeking advanced specialization, post-master’s certificate programs in nursing provide accelerated pathways. The best online post master's pmhnp programs enable nurses to become Psychiatric Mental Health Nurse Practitioners, addressing the growing demand for mental health services.

Another focused option is the 1 year post master's fnp online programs, which allow Family Nurse Practitioners to gain certification efficiently. This pathway enhances career opportunities in primary care, providing critical healthcare services to diverse populations.

Best Scientists Contributing to This Journal

Recently Published Articles